Ark Innovation ETF Trades: Sells $5M In CRISPR Therapeutics, Adds Stake In EXACT Sciences, Pacific Biosciences of California
[ad_1] Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG CRSP, valued at over $5.58 million, via its flagship fund. For ARK Innovation ETF ARKK, CRISPR is its…